Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
executive pay
Biotech
Enlivex lays off 60% of staff, 'substantially' cuts exec pay
Enlivex will lay off 60% of staff, end preclinical R&D and trim execs’ salaries as the biotech keeps cash flowing to its osteoarthritis drug.
James Waldron
Oct 19, 2026 9:41am
How Vir found the one: CEO Marianne De Backer
Apr 19, 2024 10:27am
J&J's Reed takes home $20M-plus payday in his first year
Mar 13, 2024 11:04am
J&J MedTech head Ashley McEvoy joins highest-paid execs
Mar 28, 2023 11:05am
Top 10 highest paid biopharma R&D executives in 2021
May 10, 2022 3:00am
Novavax executives' pay comes back down to Earth
Apr 21, 2022 2:39pm
